3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioma
3
Wilms Tumor
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Ependymoma
2
Cholangiocarcinoma
2
Xanthogranuloma, Juvenile
1
Neoplasms, Unknown Primary
1
Histiocytic Sarcoma
1
Central Nervous System Neoplasms
1
Interventions
Gemcitabine
43
Paclitaxel
37
pembrolizumab
36
Nivolumab
32
Docetaxel
30
Capecitabine
29
Bevacizumab
29
Oxaliplatin
28
Fluorouracil
28
Cisplatin
26
Leucovorin
24
Cyclophosphamide
23
Irinotecan
21
Radiosurgery
20
Carboplatin
20
aldesleukin
19
Cetuximab
19
Interleukin-2
16
fludarabine phosphate
15
fludarabine
15
Pemetrexed
15
Trastuzumab
14
Magnetic Resonance Spectroscopy
14
Ipilimumab
14
Fulvestrant
14
130-nm albumin-bound paclitaxel
14
Prednisone
13
Everolimus
13
Radiotherapy
12
Panitumumab
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasm Metastasis
×
ivosidenib
×
Clear all
No trials found.